AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)

Q: What does CUSIP 00288U106 represent in this 13F holders report?

CUSIP 00288U106 is the security identifier for ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share used to aggregate holder disclosures.

Q: How many institutions held ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share in Q2 2023?

167 institutional investors reported ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 00288U106

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Shares, no par value per share
Shares outstanding: 305,667,944
Total 13F shares: 124,831,655
Share change: -5,117,166
Total reported value: $809,068,808
Put/Call ratio: 65%
Price per share: $6.46
Number of holders: 167
Value change: -$42,715,484
Number of buys: 76
Number of sells: 96

Quarterly Holders Quick Answers

What is CUSIP 00288U106?
CUSIP 00288U106 identifies ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 00288U106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAILLIE GIFFORD & CO	13F	Company	6.5%	19,829,651	$149,515,570	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	4.5%	13,694,295	$103,254,984	—	31 Mar 2023	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	3.5%	10,838,025	$81,718,709	—	31 Mar 2023	13F
BAKER BROS. ADVISORS LP	13F	Company	3.4%	10,450,180	$78,794,357	—	31 Mar 2023	13F
Capital World Investors	13F	Company	3.1%	9,327,493	$70,329,297	—	31 Mar 2023	13F
John Hamer	3/4/5	Director	— class O/S missing	14,734,623	$39,783,482	—	31 Aug 2021	3/4/5
CREDIT SUISSE AG/	13F	Company	1.5%	4,608,160	$34,745,526	—	31 Mar 2023	13F
ORBIMED ADVISORS LLC	13F	Company	1.4%	4,180,768	$31,522,991	—	31 Mar 2023	13F
HARVARD MANAGEMENT CO INC	13F	Company	1.3%	4,105,095	$30,952,416	—	31 Mar 2023	13F
Founders Fund VII Management, LLC	13F	Company	1.2%	3,773,530	$28,452,416	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	1.1%	3,389,805	$25,559,130	—	31 Mar 2023	13F
LAZARD ASSET MANAGEMENT LLC	13F	Company	1.1%	3,243,199	$24,453,000	—	31 Mar 2023	13F
FEDERATED HERMES, INC.	13F	Company	0.95%	2,904,259	$21,898,113	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.92%	2,811,503	$21,199,000	—	31 Mar 2023	13F
Casdin Capital, LLC	13F	Company	0.82%	2,520,000	$19,000,800	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.71%	2,175,548	$16,403,631	—	31 Mar 2023	13F
GUARDIAN CAPITAL ADVISORS LP	13F	Company	0.58%	1,786,414	$13,022,958	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.55%	1,685,457	$12,708,346	—	31 Mar 2023	13F
NORGES BANK	13F	Company	0.52%	1,575,661	$11,880,484	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.48%	1,473,880	$11,113,055	—	31 Mar 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.48%	1,468,396	$11,071,706	—	31 Mar 2023	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.42%	1,292,592	$9,591,033	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.39%	1,206,698	$9,099,000	—	31 Mar 2023	13F
ROYAL BANK OF CANADA	13F	Company	0.38%	1,151,261	$8,681,000	—	31 Mar 2023	13F
Novo Holdings A/S	13F	Company	0.37%	1,126,915	$8,496,939	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	0.32%	989,154	$7,458,221	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.3%	909,404	$6,856,905	—	31 Mar 2023	13F
Intellectus Partners, LLC	13F	Company	0.29%	872,483	$6,578,520	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.26%	787,979	$5,941,362	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.25%	762,346	$5,748,089	—	31 Mar 2023	13F
Prosight Management, LP	13F	Company	0.25%	753,528	$5,681,601	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.23%	711,286	$5,363,000	—	31 Mar 2023	13F
Duquesne Family Office LLC	13F	Company	0.22%	659,750	$4,975,000	—	31 Mar 2023	13F
TD Waterhouse Canada Inc.	13F	Company	0.16%	482,633	$4,249,473	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.18%	560,580	$4,227,000	—	31 Mar 2023	13F
HRT FINANCIAL LP	13F	Company	0.18%	556,274	$4,194,000	—	31 Mar 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.18%	540,400	$4,074,616	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	0.17%	520,521	$3,924,728	—	31 Mar 2023	13F
Belmont Capital, LLC	13F	Company	0.17%	510,000	$3,845,400	—	31 Mar 2023	13F
Graham Capital Management, L.P.	13F	Company	0.16%	474,250	$3,575,845	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.15%	472,389	$3,561,813	—	31 Mar 2023	13F
Founders Fund Growth Management, LLC	13F	Company	0.13%	407,017	$3,068,908	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.11%	351,346	$2,649,149	—	31 Mar 2023	13F
Ester Falconer	3/4/5	Chief Technology Officer	— mixed-class rows	1,750,000 mixed-class rows	$2,362,500	—	23 Sep 2021	3/4/5
DEUTSCHE BANK AG\	13F	Company	0.1%	303,470	$2,288,164	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.1%	300,455	$2,265,000	—	31 Mar 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.1%	291,128	$2,195,105	—	31 Mar 2023	13F
Aberdeen Group plc	13F	Company	0.09%	278,528	$2,100,101	—	31 Mar 2023	13F
ExodusPoint Capital Management, LP	13F	Company	0.08%	252,192	$1,902,000	—	31 Mar 2023	13F
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS	13F	Company	0.08%	250,248	$1,886,870	—	31 Mar 2023	13F

Institutional Holders of AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL) as of Q2 2023

As of 30 Jun 2023, AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL) was held by 167 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 124,831,655 shares. The largest 10 holders included BAILLIE GIFFORD & CO, BAKER BROS. ADVISORS LP, Voya Investment Management LLC, Capital World Investors, CREDIT SUISSE AG/, ORBIMED ADVISORS LLC, ArrowMark Colorado Holdings LLC, Founders Fund VII Management, LLC, BlackRock Inc., and FEDERATED HERMES, INC.. This page lists 167 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

181

Q2 2023 holders

167

Holder diff

-14

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.